The small (corrupted) phase II NSCLC trial using Bavi has none of these, hence has NO control for comparison.
Come on Vin, you can do better than that...Again, please tell us what the normal Overall Survival OS is for a soc control group + placebo, historically speaking, in 2nd Line nsclc and why you think the combined control group in our bavi trial (soc, placebo, and some bavi 1mg) exceeded those historical soc numbers, conservatively speaking of course.
Peregrine has taken a conservative approach toward analyzing the results from the trial which included combining the placebo and 1mg/kg arms into one treatment arm (control arm), and comparing those results to the 3mg/kg arm.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.